Fidelity Investments
SANA icon

Fidelity Investments’s Sana Biotechnology SANA Stock Holding History

Fidelity Investments’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131M Sell
37,429,515
-769
-0% -$2.48K 0.01% 1122
2026
Q1 		$108M Hold
37,430,284
– – 0.01% 1136
2025
Q4 		$152M Sell
37,430,284
-1,081
-0% -$4.84K 0.01% 990
2025
Q3 		$133M Buy
37,431,365
+3,598,059
+11% +$13M 0.01% 1045
2025
Q2 		$92.4M Buy
33,833,306
+79,838
+0.2% +$165K 0.01% 1153
2025
Q1 		$56.7M Buy
33,753,468
+263,250
+0.8% +$736K ﹤0.01% 1310
2024
Q4 		$54.6M Buy
33,490,218
+1,881,043
+6% +$5.61M ﹤0.01% 1346
2024
Q3 		$131M Buy
31,609,175
+4,438,949
+16% +$23.3M 0.01% 983
2024
Q2 		$148M Buy
27,170,226
+5,127,689
+23% +$40.9M 0.01% 896
2024
Q1 		$220M Buy
22,042,537
+6,291,246
+40% +$47.1M 0.01% 750
2023
Q4 		$64.3M Sell
15,751,291
-147,438
-0.9% -$543K ﹤0.01% 1195
2023
Q3 		$61.5M Sell
15,898,729
-745,336
-4% -$4.01M 0.01% 1182
2023
Q2 		$99.2M Buy
16,644,065
+7,489,972
+82% +$43.2M 0.01% 995
2023
Q1 		$29.9M Sell
9,154,093
-15,317
-0.2% -$61.2K ﹤0.01% 1446
2022
Q4 		$36.2M Sell
9,169,410
-37,275
-0.4% -$182K ﹤0.01% 1386
2022
Q3 		$55.2M Sell
9,206,685
-541,989
-6% -$3.91M 0.01% 1210
2022
Q2 		$62.7M Buy
9,748,674
+512,607
+6% +$3.27M 0.01% 1166
2022
Q1 		$76.3M Buy
9,236,067
+608,216
+7% +$4.92M 0.01% 1196
2021
Q4 		$134M Buy
8,627,851
+175,107
+2% +$3.38M 0.01% 962
2021
Q3 		$190M Sell
8,452,744
-96,433
-1% -$2.02M 0.02% 824
2021
Q2 		$168M Sell
8,549,177
-186,213
-2% -$4.22M 0.01% 888
2021
Q1 		$292M Buy
+8,735,390
New +$284M 0.03% 620

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fidelity Investments's SANA Position: Q2 2026 in Review

Fidelity Investments reduced its Sana Biotechnology (SANA) stake by 0% in Q2 2026, selling an estimated $2.48K and leaving 37,429,515 shares worth $131M. The position accounts for 0.01% of the portfolio, ranked #1122.

Fidelity Investments first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $292M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Fidelity Investments held 37,429,515 shares of Sana Biotechnology worth $131M as of Q2 2026.
  • Fidelity Investments sold 769 Sana Biotechnology shares in Q2 2026, an estimated $2.48K.
  • Sana Biotechnology made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1122 holding.
  • Fidelity Investments first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Sana Biotechnology position peaked at $292M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.